三五互聯(300051.SZ):董事、董事長餘成斌辭職
格隆匯4月13日丨三五互聯(300051.SZ)宣佈,公司於2021年4月12日收到董事、董事長、(代)董事會祕書餘成斌的辭職信;由於近期工作調整,餘成斌自2021年4月12日起辭去董事、董事長、董事會相關專門委員會委員職務(原定董事、董事長任期為2020年11月12日-2022年8月19日)。
因餘成斌辭去前述職務後,公司董事將低於法定最低人數,餘成斌繼續履行前述職務職責,直到選出新的董事、董事長、董事會祕書或指定其他人員代行董事會祕書職責時止。餘成斌辭去前述職位後繼續在公司任職。
餘成斌當前直接持有公司股份1500股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.